Policy | October 25, 2021
India ramps up medical education with substantial investments
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
This unique record was made possible by collating hard copies of the books in a structured manner
Key takeaways of recent quarter & conference call highlights
Fujifilm India recently introduced a “Covid-19 Pneumonia Image Analysis Program” that helps in diagnosing chest CT images that helps in findings of Covid-19 pneumonia
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
The company reported 4% topline growth during the quarter driven by steady revenues in the Pharmaceuticals segment and robust growth in the Contract Research and Development Services (CRDS) segment
Subscribe To Our Newsletter & Stay Updated
